Ping An Biomedical Co., Ltd. (PASW) Income Statement
PASW FY2025 at a glance
Fiscal year ended September 30, 2025 · Chinese yuanPASW revenue and net income
Where PASW's revenue goes
FY2025Each bar shows an amount and its share of revenue. PASW kept −37.6% of revenue as net income.
PASW profit margins
PASW growth rates
to FY2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −61.0% | — | — | — |
| Gross profit | −82.5% | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
PASW income statement in Chinese yuan
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Revenue | CN¥34.1M | CN¥87.6M | CN¥82.6M |
| Cost of revenue | CN¥33.2M | CN¥82.2M | CN¥78.3M |
| Gross profit | CN¥949,505 | CN¥5.4M | CN¥4.2M |
| Sales, general & admin | CN¥6.3M | CN¥4.8M | CN¥3.2M |
| Total operating expenses | CN¥15.7M | CN¥5.4M | CN¥3.6M |
| Operating income | −CN¥14.7M | −CN¥2,039 | CN¥612,481 |
| Interest income | CN¥326,349 | CN¥2,034 | CN¥156,142 |
| Interest expense | CN¥307,055 | CN¥705,273 | CN¥1.7M |
| Income before taxes | −CN¥14.7M | −CN¥682,716 | CN¥41,686 |
| Income taxes | −CN¥1.9M | CN¥601,456 | CN¥1.0M |
| Net income | −CN¥12.8M | −CN¥1.3M | −CN¥993,937 |
| EBITDA | −CN¥14.4M | CN¥32,796 | CN¥1.8M |
| Gross margin | 2.8% | 6.2% | 5.1% |
| Operating margin | −43.1% | −0.0% | 0.7% |
| Net margin | −37.6% | −1.5% | −1.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in Chinese yuan as reported in PASW's financial statements (latest annual report filed September 30, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
PASW financial results
In fiscal year 2025 (ended September 30, 2025), Ping An Biomedical reported revenue of CN¥34.1 million, down 61.0% from the year before. It had a net loss of CN¥12.8 million, a net profit margin of −37.6%. Figures are in Chinese yuan, the currency of its financial statements.
See the PASW stock overview for the latest quote and news, or the PASW chart for price history and technical indicators.
PASW income statement FAQ
What is Ping An Biomedical's annual revenue?
Ping An Biomedical reported total revenue of CN¥34.1 million for fiscal year 2025, which ended on September 30, 2025. That was down 61.0% from CN¥87.6 million the previous year.
Is Ping An Biomedical profitable?
No. Ping An Biomedical reported a net loss of CN¥12.8 million in fiscal 2025, a net profit margin of −37.6%; its operating margin was −43.1%.
What is Ping An Biomedical's gross margin?
Ping An Biomedical's gross margin was 2.8% in fiscal 2025: for every $100 of revenue, Ping An Biomedical kept $3 after the direct cost of its products and services.
When does Ping An Biomedical's fiscal year end?
Ping An Biomedical's fiscal year ends in September. The latest annual report covers the year ended September 30, 2025 and was filed on September 30, 2025.